Thrombocytopenic purpura as first manifestation of an inapparent Hodgkin's disease.
Immune thrombocytopenic purpura (ITP) has been observed infrequently in untreated Hodgkin's disease. A patient with an ITP associated with an inapparent Hodgkin's disease, who presented a life threatening CNS haemorrhage as first clinical manifestation, is described.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000209:etiology; D003520:Cyclophosphamide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011696:Purpura, Thrombocytopenic / Q000209:etiology*; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone